Global Revenue Of Cholesterol Testing Services Market Is About USD 17.57 billion USD In 2021
Cholesterol is a waxy, fat-like molecule found in all of our body's cells. When you have too much cholesterol in your blood, it can interact with other molecules to produce plaque, which adheres to the artery walls. A lipid panel or lipid profile is another name for a full cholesterol test. It can be used by your doctor to determine the quantity of “good” and “bad” cholesterol as well as triglycerides (a form of fat) in your blood.
From an
estimated value of USD 11.96 billion in 2016, the global cholesterol testing services market is predicted to reach USD 17.57 billion by 2021, increasing at
a CAGR of 8% over the forecast period. Factors such as the rising incidence of
cardiovascular diseases and obesity, physicians' preference for laboratory
testing over self-testing, government initiatives to improve testing quality,
and the rapid growth of the geriatric population are propelling the growth of
the cholesterol testing market. However, the quick expansion of
home/self-testing and the introduction of noninvasive cholesterol testing
methods are two important issues that could limit the market's growth.
The
cholesterol testing market is divided into two categories: client type and
geographic location. Physicians/providers and hospitals; employers, health
plans, and Managed Care Organizations (MCOs); government agencies, Accountable
Care Organizations (ACOs), and Integrated Delivery Networks (IDNs); and
patients are the different types of customers in the market. In order to
deliver reliable and up-to-date diagnostic information to their clients,
companies in the market are developing novel products. Quest Diagnostics (US)
introduced QuestDirect, a new patient-initiated testing service, in November
2016.
The
cholesterol testing services market is divided into four regions: North
America, Europe, Asia, and Rest of the World. In 2016, North America is
predicted to dominate the worldwide cholesterol testing market, with the United
States accounting for a significant portion of the market. During the
projection period, Asia is expected to be the fastest-growing region in terms
of CAGR. This is due to the Asian region's enormous population, rising
prevalence of cardiovascular disorders, and growing number of testing
facilities.
Laboratory
Corporation of America Holdings (LabCorp) (US), Quest Diagnostics Incorporated
(US), Eurofins Scientific (Luxembourg), Spectra Laboratories Inc. (US), Unilabs
(Switzerland), SYNLAB International GmbH (Germany), Bio-Reference Laboratories
Inc. (US), Clinical Reference Laboratory, Inc. (CRL) (US), ACM Medical
Laboratory (US) are some of the major players in the cholesterol testing market
(China).

Comments
Post a Comment